Index by author

01 August 1999; volume 14, issue 2

A

  1. Aalbers, R

    1. Berge, MV et al "A man with upper respiratory tract infections, general weakness and fever." European Respiratory Journal 14.2 (1999): 469-470. Web. 27 Oct. 2021.

  2. Accordini, S

    1. Cerveri, I et al "International variations in asthma treatment compliance: the results of the European Community Respiratory Health Survey (ECRHS)." European Respiratory Journal 14.2 (1999): 288-294. Web. 27 Oct. 2021.

  3. Adams, JE

    1. Haworth, CS et al "Hip fracture and bone histomorphometry in a young adult with cystic fibrosis." European Respiratory Journal 14.2 (1999): 478-479. Web. 27 Oct. 2021.

  4. Akkermans, MA

    1. Coppoolse, R et al "Interval versus continuous training in patients with severe COPD: a randomized clinical trial." European Respiratory Journal 14.2 (1999): 258-263. Web. 27 Oct. 2021.

  5. Aldridge, RE

    1. Hancox, RJ et al "Tolerance to beta-agonists during acute bronchoconstriction." European Respiratory Journal 14.2 (1999): 283-287. Web. 27 Oct. 2021.

  6. Ando, M

    1. Suga, M et al "Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases." European Respiratory Journal 14.2 (1999): 376-382. Web. 27 Oct. 2021.
    2. Iyonaga, K et al "Elevated bronchoalveolar concentrations of MCP-1 in patients with pulmonary alveolar proteinosis." European Respiratory Journal 14.2 (1999): 383-389. Web. 27 Oct. 2021.

  7. Ansari, T

    1. Majumdar, S et al "Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies." European Respiratory Journal 14.2 (1999): 251-257. Web. 27 Oct. 2021.

  8. Antoine, M

    1. Wislez, M et al "Lymphoma of pulmonary mucosa-associated lymphoid tissue: CT scan findings and pathological correlations." European Respiratory Journal 14.2 (1999): 423-429. Web. 27 Oct. 2021.

  9. Artvinli, M

    1. Selcuk, ZT et al "Malignant mesothelioma and erionite exposure." European Respiratory Journal 14.2 (1999): 480-481. Web. 27 Oct. 2021.

  10. Attias, D

    1. Vaiman, E et al "T-cell chronic lymphocytic leukaemia with pulmonary involvement and relapsing BOOP." European Respiratory Journal 14.2 (1999): 471-474. Web. 27 Oct. 2021.

  11. Ava, JD

    1. Choudat, D et al "Quantification of the dose of inhaled flour: relation with nonspecific bronchial and immunological reactivities." European Respiratory Journal 14.2 (1999): 328-334. Web. 27 Oct. 2021.

B

  1. Baarends, EM

    1. Coppoolse, R et al "Interval versus continuous training in patients with severe COPD: a randomized clinical trial." European Respiratory Journal 14.2 (1999): 258-263. Web. 27 Oct. 2021.

  2. Bara, J

    1. Labat, C et al "M1/MUC5AC mucin released by human airways in vitro." European Respiratory Journal 14.2 (1999): 390-395. Web. 27 Oct. 2021.

  3. Baris, YI

    1. Selcuk, ZT et al "Malignant mesothelioma and erionite exposure." European Respiratory Journal 14.2 (1999): 480-481. Web. 27 Oct. 2021.

  4. Bauer, T

    1. Ewig, S et al "Comparative validation of prognostic rules for community-acquired pneumonia in an elderly population." European Respiratory Journal 14.2 (1999): 370-375. Web. 27 Oct. 2021.

  5. Baughman, RP

    1. Haslam, PL, and RP Baughman. "Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL." European Respiratory Journal 14.2 (1999): 245-248. Web. 27 Oct. 2021.

  6. Bazot, M

    1. Wislez, M et al "Lymphoma of pulmonary mucosa-associated lymphoid tissue: CT scan findings and pathological correlations." European Respiratory Journal 14.2 (1999): 423-429. Web. 27 Oct. 2021.

  7. Ben-Arie, Y

    1. Vaiman, E et al "T-cell chronic lymphocytic leukaemia with pulmonary involvement and relapsing BOOP." European Respiratory Journal 14.2 (1999): 471-474. Web. 27 Oct. 2021.

  8. Berge, MV

    1. Berge, MV et al "A man with upper respiratory tract infections, general weakness and fever." European Respiratory Journal 14.2 (1999): 469-470. Web. 27 Oct. 2021.

  9. Berning, SE

    1. Gilljam, M et al "Therapeutic drug monitoring in patients with cystic fibrosis and mycobacterial disease." European Respiratory Journal 14.2 (1999): 347-351. Web. 27 Oct. 2021.

  10. Black, CM

    1. Majumdar, S et al "Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies." European Respiratory Journal 14.2 (1999): 251-257. Web. 27 Oct. 2021.

  11. Bodner, C

    1. Bodner, C et al "Bronchial hyperresponsiveness and adult onset wheeze: the influence of atopy." European Respiratory Journal 14.2 (1999): 335-338. Web. 27 Oct. 2021.

  12. Boule, M

    1. Osika, E et al "Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease." European Respiratory Journal 14.2 (1999): 339-346. Web. 27 Oct. 2021.

  13. Boutellier, U

    1. Perret, C et al "Noninvasive measurement of respiratory muscle performance after exhaustive endurance exercise." European Respiratory Journal 14.2 (1999): 264-269. Web. 27 Oct. 2021.

  14. Bradding, P

    1. Roberts, JA et al "The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma." European Respiratory Journal 14.2 (1999): 275-282. Web. 27 Oct. 2021.

  15. Branscheid, D

    1. Schmidt, D et al "Passive sensitization of human airways increases responsiveness to leukotriene C4." European Respiratory Journal 14.2 (1999): 315-319. Web. 27 Oct. 2021.

  16. Brink, C

    1. Labat, C et al "M1/MUC5AC mucin released by human airways in vitro." European Respiratory Journal 14.2 (1999): 390-395. Web. 27 Oct. 2021.

  17. Britten, KM

    1. Roberts, JA et al "The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma." European Respiratory Journal 14.2 (1999): 275-282. Web. 27 Oct. 2021.

  18. Broome, U

    1. Palmer, U et al "Epidermal growth factor receptor ligands are chemoattractants for normal human mesothelial cells." European Respiratory Journal 14.2 (1999): 405-411. Web. 27 Oct. 2021.

  19. Burger, R

    1. Burger, R, S Fanconi, and B Simma. "Paralysis of ventilated newborn babies does not influence resistance of the total respiratory system." European Respiratory Journal 14.2 (1999): 357-362. Web. 27 Oct. 2021.

  20. Bush, A

    1. Bush, A. "Left bronchial isomerism, normal atrial arrangement and bronchomalacia mimicking asthma: a new syndrome?." European Respiratory Journal 14.2 (1999): 475-477. Web. 27 Oct. 2021.

C

  1. Cadranel, J

    1. Wislez, M et al "Lymphoma of pulmonary mucosa-associated lymphoid tissue: CT scan findings and pathological correlations." European Respiratory Journal 14.2 (1999): 423-429. Web. 27 Oct. 2021.

  2. Cardell, LO

    1. Linden, A et al "Bronchodilation by pituitary adenylate cyclase-activating peptide and related peptides." European Respiratory Journal 14.2 (1999): 443-451. Web. 27 Oct. 2021.

  3. Carette, MF

    1. Wislez, M et al "Lymphoma of pulmonary mucosa-associated lymphoid tissue: CT scan findings and pathological correlations." European Respiratory Journal 14.2 (1999): 423-429. Web. 27 Oct. 2021.

  4. Cavaillon, JM

    1. Osika, E et al "Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease." European Respiratory Journal 14.2 (1999): 339-346. Web. 27 Oct. 2021.

  5. Cerveri, I

    1. Cerveri, I et al "International variations in asthma treatment compliance: the results of the European Community Respiratory Health Survey (ECRHS)." European Respiratory Journal 14.2 (1999): 288-294. Web. 27 Oct. 2021.

  6. Chadelat, K

    1. Osika, E et al "Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease." European Respiratory Journal 14.2 (1999): 339-346. Web. 27 Oct. 2021.

  7. Choudat, D

    1. Choudat, D et al "Quantification of the dose of inhaled flour: relation with nonspecific bronchial and immunological reactivities." European Respiratory Journal 14.2 (1999): 328-334. Web. 27 Oct. 2021.

  8. Clement, A

    1. Osika, E et al "Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease." European Respiratory Journal 14.2 (1999): 339-346. Web. 27 Oct. 2021.

  9. Cole, PJ

    1. Dowling, RB et al "Effect of fluticasone propionate and salmeterol on Pseudomonas aeruginosa infection of the respiratory mucosa in vitro." European Respiratory Journal 14.2 (1999): 363-369. Web. 27 Oct. 2021.

  10. Conso, F

    1. Choudat, D et al "Quantification of the dose of inhaled flour: relation with nonspecific bronchial and immunological reactivities." European Respiratory Journal 14.2 (1999): 328-334. Web. 27 Oct. 2021.

  11. Coplu, L

    1. Selcuk, ZT et al "Malignant mesothelioma and erionite exposure." European Respiratory Journal 14.2 (1999): 480-481. Web. 27 Oct. 2021.

  12. Coppoolse, R

    1. Coppoolse, R et al "Interval versus continuous training in patients with severe COPD: a randomized clinical trial." European Respiratory Journal 14.2 (1999): 258-263. Web. 27 Oct. 2021.

  13. Corsico, A

    1. Cerveri, I et al "International variations in asthma treatment compliance: the results of the European Community Respiratory Health Survey (ECRHS)." European Respiratory Journal 14.2 (1999): 288-294. Web. 27 Oct. 2021.

  14. Cowan, JO

    1. Hancox, RJ et al "Tolerance to beta-agonists during acute bronchoconstriction." European Respiratory Journal 14.2 (1999): 283-287. Web. 27 Oct. 2021.

D

  1. Decramer, M

    1. Troosters, T, R Gosselink, and M Decramer. "Six minute walking distance in healthy elderly subjects." European Respiratory Journal 14.2 (1999): 270-274. Web. 27 Oct. 2021.
    2. Houtmeyers, E et al "Effects of drugs on mucus clearance." European Respiratory Journal 14.2 (1999): 452-467. Web. 27 Oct. 2021.

  2. de Marco, R

    1. Cerveri, I et al "International variations in asthma treatment compliance: the results of the European Community Respiratory Health Survey (ECRHS)." European Respiratory Journal 14.2 (1999): 288-294. Web. 27 Oct. 2021.

  3. de Perrot, M

    1. de Perrot, M et al "Influence of age on operative mortality and long-term survival after lung resection for bronchogenic carcinoma." European Respiratory Journal 14.2 (1999): 419-422. Web. 27 Oct. 2021.

  4. Derenne, JP

    1. Tantucci, C et al "Dynamic hyperinflation and flow limitation during methacholine-induced bronchoconstriction in asthma." European Respiratory Journal 14.2 (1999): 295-301. Web. 27 Oct. 2021.

  5. Dessanges, JF

    1. Choudat, D et al "Quantification of the dose of inhaled flour: relation with nonspecific bronchial and immunological reactivities." European Respiratory Journal 14.2 (1999): 328-334. Web. 27 Oct. 2021.

  6. Dodd, ME

    1. Haworth, CS et al "Hip fracture and bone histomorphometry in a young adult with cystic fibrosis." European Respiratory Journal 14.2 (1999): 478-479. Web. 27 Oct. 2021.

  7. Douglas, JG

    1. Bodner, C et al "Bronchial hyperresponsiveness and adult onset wheeze: the influence of atopy." European Respiratory Journal 14.2 (1999): 335-338. Web. 27 Oct. 2021.

  8. Dowling, RB

    1. Dowling, RB et al "Effect of fluticasone propionate and salmeterol on Pseudomonas aeruginosa infection of the respiratory mucosa in vitro." European Respiratory Journal 14.2 (1999): 363-369. Web. 27 Oct. 2021.

  9. du Bois, RM

    1. Majumdar, S et al "Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies." European Respiratory Journal 14.2 (1999): 251-257. Web. 27 Oct. 2021.

  10. Duguet, A

    1. Tantucci, C et al "Dynamic hyperinflation and flow limitation during methacholine-induced bronchoconstriction in asthma." European Respiratory Journal 14.2 (1999): 295-301. Web. 27 Oct. 2021.

  11. Durham, S

    1. Durham, S. "Long acting inhaled beta2-agonists: anti-inflammatory effects not evident during treatment of day to day asthma." European Respiratory Journal 14.2 (1999): 249-250. Web. 27 Oct. 2021.

E

  1. Elborn, JS

    1. Hendry, J et al "Cystic fibrosis: inflammatory response to infection with Burkholderia cepacia and Pseudomonas aeruginosa." European Respiratory Journal 14.2 (1999): 435-438. Web. 27 Oct. 2021.

  2. Ellaffi, M

    1. Tantucci, C et al "Dynamic hyperinflation and flow limitation during methacholine-induced bronchoconstriction in asthma." European Respiratory Journal 14.2 (1999): 295-301. Web. 27 Oct. 2021.

  3. Emri, S

    1. Selcuk, ZT et al "Malignant mesothelioma and erionite exposure." European Respiratory Journal 14.2 (1999): 480-481. Web. 27 Oct. 2021.

  4. Endoh, N

    1. Mashito, Y et al "Sensory nerve activation in airway microvascular permeability in guinea-pig late allergic response." European Respiratory Journal 14.2 (1999): 320-327. Web. 27 Oct. 2021.

  5. Ewig, S

    1. Ewig, S et al "Comparative validation of prognostic rules for community-acquired pneumonia in an elderly population." European Respiratory Journal 14.2 (1999): 370-375. Web. 27 Oct. 2021.

F

  1. Fabries, JF

    1. Choudat, D et al "Quantification of the dose of inhaled flour: relation with nonspecific bronchial and immunological reactivities." European Respiratory Journal 14.2 (1999): 328-334. Web. 27 Oct. 2021.

  2. Fanconi, S

    1. Burger, R, S Fanconi, and B Simma. "Paralysis of ventilated newborn babies does not influence resistance of the total respiratory system." European Respiratory Journal 14.2 (1999): 357-362. Web. 27 Oct. 2021.

  3. Fernandes, LB

    1. Fernandes, LB, PJ Henry, and RG Goldie. "Endothelin-1 potentiates cholinergic nerve-mediated contraction in human isolated bronchus." European Respiratory Journal 14.2 (1999): 439-442. Web. 27 Oct. 2021.

  4. Fitting, C

    1. Osika, E et al "Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease." European Respiratory Journal 14.2 (1999): 339-346. Web. 27 Oct. 2021.

  5. Flannery, EM

    1. Hancox, RJ et al "Tolerance to beta-agonists during acute bronchoconstriction." European Respiratory Journal 14.2 (1999): 283-287. Web. 27 Oct. 2021.

  6. Freemont, AJ

    1. Haworth, CS et al "Hip fracture and bone histomorphometry in a young adult with cystic fibrosis." European Respiratory Journal 14.2 (1999): 478-479. Web. 27 Oct. 2021.

  7. Friend, J

    1. Bodner, C et al "Bronchial hyperresponsiveness and adult onset wheeze: the influence of atopy." European Respiratory Journal 14.2 (1999): 335-338. Web. 27 Oct. 2021.

  8. Fujimoto, K

    1. Takanashi, S et al "Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers." European Respiratory Journal 14.2 (1999): 309-314. Web. 27 Oct. 2021.

G

  1. Garlepp, MJ

    1. Watkins, DN et al "Expression and localization of cyclo-oxygenase isoforms in non-small cell lung cancer." European Respiratory Journal 14.2 (1999): 412-418. Web. 27 Oct. 2021.

  2. Gascard, JP

    1. Labat, C et al "M1/MUC5AC mucin released by human airways in vitro." European Respiratory Journal 14.2 (1999): 390-395. Web. 27 Oct. 2021.

  3. Gayan-Ramirez, G

    1. Houtmeyers, E et al "Effects of drugs on mucus clearance." European Respiratory Journal 14.2 (1999): 452-467. Web. 27 Oct. 2021.

  4. Gilljam, M

    1. Gilljam, M et al "Therapeutic drug monitoring in patients with cystic fibrosis and mycobacterial disease." European Respiratory Journal 14.2 (1999): 347-351. Web. 27 Oct. 2021.

  5. Ginsburg, I

    1. Ginsburg, I. ""Cross-talk" among a multiplicity of pro-inflammatory agents: main cause of tissue damage in pulmonary inflammation?." European Respiratory Journal 14.2 (1999): 481-482. Web. 27 Oct. 2021.

  6. Gizycki, M

    1. Majumdar, S et al "Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies." European Respiratory Journal 14.2 (1999): 251-257. Web. 27 Oct. 2021.

  7. Godden, D

    1. Bodner, C et al "Bronchial hyperresponsiveness and adult onset wheeze: the influence of atopy." European Respiratory Journal 14.2 (1999): 335-338. Web. 27 Oct. 2021.

  8. Goke, N

    1. Ewig, S et al "Comparative validation of prognostic rules for community-acquired pneumonia in an elderly population." European Respiratory Journal 14.2 (1999): 370-375. Web. 27 Oct. 2021.

  9. Goldie, RG

    1. Fernandes, LB, PJ Henry, and RG Goldie. "Endothelin-1 potentiates cholinergic nerve-mediated contraction in human isolated bronchus." European Respiratory Journal 14.2 (1999): 439-442. Web. 27 Oct. 2021.

  10. Gorski, P

    1. Krakowiak, A, B Szulc, and P Gorski. "Allergy to laboratory animals in children of parents occupationally exposed to mice, rats and hamsters." European Respiratory Journal 14.2 (1999): 352-356. Web. 27 Oct. 2021.

  11. Gosselink, R

    1. Troosters, T, R Gosselink, and M Decramer. "Six minute walking distance in healthy elderly subjects." European Respiratory Journal 14.2 (1999): 270-274. Web. 27 Oct. 2021.
    2. Houtmeyers, E et al "Effects of drugs on mucus clearance." European Respiratory Journal 14.2 (1999): 452-467. Web. 27 Oct. 2021.

  12. Gratziou, C

    1. Roberts, JA et al "The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma." European Respiratory Journal 14.2 (1999): 275-282. Web. 27 Oct. 2021.

H

  1. Hancox, RJ

    1. Hancox, RJ et al "Tolerance to beta-agonists during acute bronchoconstriction." European Respiratory Journal 14.2 (1999): 283-287. Web. 27 Oct. 2021.

  2. Hasegawa, Y

    1. Takanashi, S et al "Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers." European Respiratory Journal 14.2 (1999): 309-314. Web. 27 Oct. 2021.

  3. Haslam, PL

    1. Haslam, PL, and RP Baughman. "Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL." European Respiratory Journal 14.2 (1999): 245-248. Web. 27 Oct. 2021.

  4. Haworth, CS

    1. Haworth, CS et al "Hip fracture and bone histomorphometry in a young adult with cystic fibrosis." European Respiratory Journal 14.2 (1999): 478-479. Web. 27 Oct. 2021.

  5. Hendry, J

    1. Hendry, J et al "Cystic fibrosis: inflammatory response to infection with Burkholderia cepacia and Pseudomonas aeruginosa." European Respiratory Journal 14.2 (1999): 435-438. Web. 27 Oct. 2021.

  6. Henry, PJ

    1. Fernandes, LB, PJ Henry, and RG Goldie. "Endothelin-1 potentiates cholinergic nerve-mediated contraction in human isolated bronchus." European Respiratory Journal 14.2 (1999): 439-442. Web. 27 Oct. 2021.

  7. Herbison, GP

    1. Hancox, RJ et al "Tolerance to beta-agonists during acute bronchoconstriction." European Respiratory Journal 14.2 (1999): 283-287. Web. 27 Oct. 2021.

  8. Holgate, ST

    1. Roberts, JA et al "The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma." European Respiratory Journal 14.2 (1999): 275-282. Web. 27 Oct. 2021.

  9. Houtmeyers, E

    1. Houtmeyers, E et al "Effects of drugs on mucus clearance." European Respiratory Journal 14.2 (1999): 452-467. Web. 27 Oct. 2021.

  10. Howarth, PH

    1. Roberts, JA et al "The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma." European Respiratory Journal 14.2 (1999): 275-282. Web. 27 Oct. 2021.

I

  1. Ichinose, M

    1. Mashito, Y et al "Sensory nerve activation in airway microvascular permeability in guinea-pig late allergic response." European Respiratory Journal 14.2 (1999): 320-327. Web. 27 Oct. 2021.

  2. Ichiyasu, H

    1. Suga, M et al "Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases." European Respiratory Journal 14.2 (1999): 376-382. Web. 27 Oct. 2021.
    2. Iyonaga, K et al "Elevated bronchoalveolar concentrations of MCP-1 in patients with pulmonary alveolar proteinosis." European Respiratory Journal 14.2 (1999): 383-389. Web. 27 Oct. 2021.

  3. Iyonaga, K

    1. Suga, M et al "Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases." European Respiratory Journal 14.2 (1999): 376-382. Web. 27 Oct. 2021.
    2. Iyonaga, K et al "Elevated bronchoalveolar concentrations of MCP-1 in patients with pulmonary alveolar proteinosis." European Respiratory Journal 14.2 (1999): 383-389. Web. 27 Oct. 2021.

J

  1. Janssen, PP

    1. Coppoolse, R et al "Interval versus continuous training in patients with severe COPD: a randomized clinical trial." European Respiratory Journal 14.2 (1999): 258-263. Web. 27 Oct. 2021.

  2. Jeffery, PK

    1. Majumdar, S et al "Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies." European Respiratory Journal 14.2 (1999): 251-257. Web. 27 Oct. 2021.

  3. Jeong, JH

    1. Koh, YY et al "Development of wheezing in patients with cough variant asthma during an increase in airway responsiveness." European Respiratory Journal 14.2 (1999): 302-308. Web. 27 Oct. 2021.

  4. Johns, DP

    1. Ward, RJ et al "A critical evaluation of the Mefar dosimeter." European Respiratory Journal 14.2 (1999): 430-434. Web. 27 Oct. 2021.

  5. Johnson, M

    1. Dowling, RB et al "Effect of fluticasone propionate and salmeterol on Pseudomonas aeruginosa infection of the respiratory mucosa in vitro." European Respiratory Journal 14.2 (1999): 363-369. Web. 27 Oct. 2021.

  6. Julius, AJ

    1. Berge, MV et al "A man with upper respiratory tract infections, general weakness and fever." European Respiratory Journal 14.2 (1999): 469-470. Web. 27 Oct. 2021.

K

  1. Kalyoncu, F

    1. Selcuk, ZT et al "Malignant mesothelioma and erionite exposure." European Respiratory Journal 14.2 (1999): 480-481. Web. 27 Oct. 2021.

  2. Kanehira, Y

    1. Takanashi, S et al "Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers." European Respiratory Journal 14.2 (1999): 309-314. Web. 27 Oct. 2021.

  3. Kim, CK

    1. Koh, YY et al "Development of wheezing in patients with cough variant asthma during an increase in airway responsiveness." European Respiratory Journal 14.2 (1999): 302-308. Web. 27 Oct. 2021.

  4. Kleinfeld, T

    1. Ewig, S et al "Comparative validation of prognostic rules for community-acquired pneumonia in an elderly population." European Respiratory Journal 14.2 (1999): 370-375. Web. 27 Oct. 2021.

  5. Klominek, J

    1. Palmer, U et al "Epidermal growth factor receptor ligands are chemoattractants for normal human mesothelial cells." European Respiratory Journal 14.2 (1999): 405-411. Web. 27 Oct. 2021.

  6. Koh, YY

    1. Koh, YY et al "Development of wheezing in patients with cough variant asthma during an increase in airway responsiveness." European Respiratory Journal 14.2 (1999): 302-308. Web. 27 Oct. 2021.

  7. Krakowiak, A

    1. Krakowiak, A, B Szulc, and P Gorski. "Allergy to laboratory animals in children of parents occupationally exposed to mice, rats and hamsters." European Respiratory Journal 14.2 (1999): 352-356. Web. 27 Oct. 2021.

L

  1. Labat, C

    1. Labat, C et al "M1/MUC5AC mucin released by human airways in vitro." European Respiratory Journal 14.2 (1999): 390-395. Web. 27 Oct. 2021.

  2. Larsson, LO

    1. Gilljam, M et al "Therapeutic drug monitoring in patients with cystic fibrosis and mycobacterial disease." European Respiratory Journal 14.2 (1999): 347-351. Web. 27 Oct. 2021.

  3. Legge, J

    1. Bodner, C et al "Bronchial hyperresponsiveness and adult onset wheeze: the influence of atopy." European Respiratory Journal 14.2 (1999): 335-338. Web. 27 Oct. 2021.

  4. Lenzo, JC

    1. Watkins, DN et al "Expression and localization of cyclo-oxygenase isoforms in non-small cell lung cancer." European Respiratory Journal 14.2 (1999): 412-418. Web. 27 Oct. 2021.

  5. Leonard, RF

    1. Ward, RJ et al "A critical evaluation of the Mefar dosimeter." European Respiratory Journal 14.2 (1999): 430-434. Web. 27 Oct. 2021.

  6. Li, D

    1. Majumdar, S et al "Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies." European Respiratory Journal 14.2 (1999): 251-257. Web. 27 Oct. 2021.

  7. Liakakos, P

    1. Ward, RJ et al "A critical evaluation of the Mefar dosimeter." European Respiratory Journal 14.2 (1999): 430-434. Web. 27 Oct. 2021.

  8. Licker, M

    1. de Perrot, M et al "Influence of age on operative mortality and long-term survival after lung resection for bronchogenic carcinoma." European Respiratory Journal 14.2 (1999): 419-422. Web. 27 Oct. 2021.

  9. Linden, A

    1. Linden, A et al "Bronchodilation by pituitary adenylate cyclase-activating peptide and related peptides." European Respiratory Journal 14.2 (1999): 443-451. Web. 27 Oct. 2021.

  10. Little, J

    1. Bodner, C et al "Bronchial hyperresponsiveness and adult onset wheeze: the influence of atopy." European Respiratory Journal 14.2 (1999): 335-338. Web. 27 Oct. 2021.

  11. Liu, Z

    1. Palmer, U et al "Epidermal growth factor receptor ligands are chemoattractants for normal human mesothelial cells." European Respiratory Journal 14.2 (1999): 405-411. Web. 27 Oct. 2021.

  12. Locatelli, F

    1. Cerveri, I et al "International variations in asthma treatment compliance: the results of the European Community Respiratory Health Survey (ECRHS)." European Respiratory Journal 14.2 (1999): 288-294. Web. 27 Oct. 2021.

M

  1. Maeda, H

    1. Takata, Y et al "Phospholipase A2 augments contraction and intracellular calcium mobilization through thromboxane A2 in bovine tracheal smooth muscle." European Respiratory Journal 14.2 (1999): 396-404. Web. 27 Oct. 2021.

  2. Magnussen, H

    1. Schmidt, D et al "Passive sensitization of human airways increases responsiveness to leukotriene C4." European Respiratory Journal 14.2 (1999): 315-319. Web. 27 Oct. 2021.

  3. Majumdar, S

    1. Majumdar, S et al "Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies." European Respiratory Journal 14.2 (1999): 251-257. Web. 27 Oct. 2021.

  4. Martin, JC

    1. Choudat, D et al "Quantification of the dose of inhaled flour: relation with nonspecific bronchial and immunological reactivities." European Respiratory Journal 14.2 (1999): 328-334. Web. 27 Oct. 2021.

  5. Mashito, Y

    1. Mashito, Y et al "Sensory nerve activation in airway microvascular permeability in guinea-pig late allergic response." European Respiratory Journal 14.2 (1999): 320-327. Web. 27 Oct. 2021.

  6. Mawer, EB

    1. Haworth, CS et al "Hip fracture and bone histomorphometry in a young adult with cystic fibrosis." European Respiratory Journal 14.2 (1999): 478-479. Web. 27 Oct. 2021.

  7. Mayaud, C

    1. Wislez, M et al "Lymphoma of pulmonary mucosa-associated lymphoid tissue: CT scan findings and pathological correlations." European Respiratory Journal 14.2 (1999): 423-429. Web. 27 Oct. 2021.

  8. McLachlan, CR

    1. Hancox, RJ et al "Tolerance to beta-agonists during acute bronchoconstriction." European Respiratory Journal 14.2 (1999): 283-287. Web. 27 Oct. 2021.

  9. Milic-Emili, J

    1. Tantucci, C et al "Dynamic hyperinflation and flow limitation during methacholine-induced bronchoconstriction in asthma." European Respiratory Journal 14.2 (1999): 295-301. Web. 27 Oct. 2021.

  10. Milleron, B

    1. Wislez, M et al "Lymphoma of pulmonary mucosa-associated lymphoid tissue: CT scan findings and pathological correlations." European Respiratory Journal 14.2 (1999): 423-429. Web. 27 Oct. 2021.

  11. Miura, M

    1. Mashito, Y et al "Sensory nerve activation in airway microvascular permeability in guinea-pig late allergic response." European Respiratory Journal 14.2 (1999): 320-327. Web. 27 Oct. 2021.

  12. Miyakawa, H

    1. Iyonaga, K et al "Elevated bronchoalveolar concentrations of MCP-1 in patients with pulmonary alveolar proteinosis." European Respiratory Journal 14.2 (1999): 383-389. Web. 27 Oct. 2021.

  13. Mostert, R

    1. Coppoolse, R et al "Interval versus continuous training in patients with severe COPD: a randomized clinical trial." European Respiratory Journal 14.2 (1999): 258-263. Web. 27 Oct. 2021.

N

  1. Nadel, JA

    1. Linden, A et al "Bronchodilation by pituitary adenylate cyclase-activating peptide and related peptides." European Respiratory Journal 14.2 (1999): 443-451. Web. 27 Oct. 2021.

  2. Nijboer, EW

    1. Berge, MV et al "A man with upper respiratory tract infections, general weakness and fever." European Respiratory Journal 14.2 (1999): 469-470. Web. 27 Oct. 2021.

  3. Nishimura, Y

    1. Takata, Y et al "Phospholipase A2 augments contraction and intracellular calcium mobilization through thromboxane A2 in bovine tracheal smooth muscle." European Respiratory Journal 14.2 (1999): 396-404. Web. 27 Oct. 2021.

  4. Nixon, L

    1. Hendry, J et al "Cystic fibrosis: inflammatory response to infection with Burkholderia cepacia and Pseudomonas aeruginosa." European Respiratory Journal 14.2 (1999): 435-438. Web. 27 Oct. 2021.

O

  1. Odeh, M

    1. Vaiman, E et al "T-cell chronic lymphocytic leukaemia with pulmonary involvement and relapsing BOOP." European Respiratory Journal 14.2 (1999): 471-474. Web. 27 Oct. 2021.

  2. Okamura, K

    1. Takanashi, S et al "Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers." European Respiratory Journal 14.2 (1999): 309-314. Web. 27 Oct. 2021.

  3. Oliven, A

    1. Vaiman, E et al "T-cell chronic lymphocytic leukaemia with pulmonary involvement and relapsing BOOP." European Respiratory Journal 14.2 (1999): 471-474. Web. 27 Oct. 2021.

  4. Osika, E

    1. Osika, E et al "Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease." European Respiratory Journal 14.2 (1999): 339-346. Web. 27 Oct. 2021.

P

  1. Palmer, U

    1. Palmer, U et al "Epidermal growth factor receptor ligands are chemoattractants for normal human mesothelial cells." European Respiratory Journal 14.2 (1999): 405-411. Web. 27 Oct. 2021.

  2. Pantelidis, P

    1. Majumdar, S et al "Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies." European Respiratory Journal 14.2 (1999): 251-257. Web. 27 Oct. 2021.

  3. Park, Y

    1. Koh, YY et al "Development of wheezing in patients with cough variant asthma during an increase in airway responsiveness." European Respiratory Journal 14.2 (1999): 302-308. Web. 27 Oct. 2021.

  4. Peloquin, CA

    1. Gilljam, M et al "Therapeutic drug monitoring in patients with cystic fibrosis and mycobacterial disease." European Respiratory Journal 14.2 (1999): 347-351. Web. 27 Oct. 2021.

  5. Perret, C

    1. Perret, C et al "Noninvasive measurement of respiratory muscle performance after exhaustive endurance exercise." European Respiratory Journal 14.2 (1999): 264-269. Web. 27 Oct. 2021.

  6. Pfeiffer, R

    1. Perret, C et al "Noninvasive measurement of respiratory muscle performance after exhaustive endurance exercise." European Respiratory Journal 14.2 (1999): 264-269. Web. 27 Oct. 2021.

R

  1. Rabe, KF

    1. Schmidt, D et al "Passive sensitization of human airways increases responsiveness to leukotriene C4." European Respiratory Journal 14.2 (1999): 315-319. Web. 27 Oct. 2021.

  2. Reich, JM

    1. Reich, JM. "Sarcoidosis and cancer revisited." European Respiratory Journal 14.2 (1999): 482-483. Web. 27 Oct. 2021.

  3. Reid, DW

    1. Ward, RJ et al "A critical evaluation of the Mefar dosimeter." European Respiratory Journal 14.2 (1999): 430-434. Web. 27 Oct. 2021.

  4. Reymond, MA

    1. de Perrot, M et al "Influence of age on operative mortality and long-term survival after lung resection for bronchogenic carcinoma." European Respiratory Journal 14.2 (1999): 419-422. Web. 27 Oct. 2021.

  5. Robert, J

    1. de Perrot, M et al "Influence of age on operative mortality and long-term survival after lung resection for bronchogenic carcinoma." European Respiratory Journal 14.2 (1999): 419-422. Web. 27 Oct. 2021.

  6. Roberts, JA

    1. Roberts, JA et al "The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma." European Respiratory Journal 14.2 (1999): 275-282. Web. 27 Oct. 2021.

  7. Ross, S

    1. Bodner, C et al "Bronchial hyperresponsiveness and adult onset wheeze: the influence of atopy." European Respiratory Journal 14.2 (1999): 335-338. Web. 27 Oct. 2021.

  8. Ruehlmann, E

    1. Schmidt, D et al "Passive sensitization of human airways increases responsiveness to leukotriene C4." European Respiratory Journal 14.2 (1999): 315-319. Web. 27 Oct. 2021.

S

  1. Sahin, AA

    1. Selcuk, ZT et al "Malignant mesothelioma and erionite exposure." European Respiratory Journal 14.2 (1999): 480-481. Web. 27 Oct. 2021.

  2. Saita, N

    1. Suga, M et al "Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases." European Respiratory Journal 14.2 (1999): 376-382. Web. 27 Oct. 2021.

  3. Satoh, K

    1. Takanashi, S et al "Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers." European Respiratory Journal 14.2 (1999): 309-314. Web. 27 Oct. 2021.

  4. Schafer, H

    1. Ewig, S et al "Comparative validation of prognostic rules for community-acquired pneumonia in an elderly population." European Respiratory Journal 14.2 (1999): 370-375. Web. 27 Oct. 2021.

  5. Schmidt, D

    1. Schmidt, D et al "Passive sensitization of human airways increases responsiveness to leukotriene C4." European Respiratory Journal 14.2 (1999): 315-319. Web. 27 Oct. 2021.

  6. Schols, AM

    1. Coppoolse, R et al "Interval versus continuous training in patients with severe COPD: a randomized clinical trial." European Respiratory Journal 14.2 (1999): 258-263. Web. 27 Oct. 2021.

  7. Seaton, A

    1. Bodner, C et al "Bronchial hyperresponsiveness and adult onset wheeze: the influence of atopy." European Respiratory Journal 14.2 (1999): 335-338. Web. 27 Oct. 2021.

  8. Segal, A

    1. Watkins, DN et al "Expression and localization of cyclo-oxygenase isoforms in non-small cell lung cancer." European Respiratory Journal 14.2 (1999): 412-418. Web. 27 Oct. 2021.

  9. Seifert, K

    1. Ewig, S et al "Comparative validation of prognostic rules for community-acquired pneumonia in an elderly population." European Respiratory Journal 14.2 (1999): 370-375. Web. 27 Oct. 2021.

  10. Selby, PL

    1. Haworth, CS et al "Hip fracture and bone histomorphometry in a young adult with cystic fibrosis." European Respiratory Journal 14.2 (1999): 478-479. Web. 27 Oct. 2021.

  11. Selcuk, ZT

    1. Selcuk, ZT et al "Malignant mesothelioma and erionite exposure." European Respiratory Journal 14.2 (1999): 480-481. Web. 27 Oct. 2021.

  12. Shale, DJ

    1. Hendry, J et al "Cystic fibrosis: inflammatory response to infection with Burkholderia cepacia and Pseudomonas aeruginosa." European Respiratory Journal 14.2 (1999): 435-438. Web. 27 Oct. 2021.

  13. Shirato, K

    1. Mashito, Y et al "Sensory nerve activation in airway microvascular permeability in guinea-pig late allergic response." European Respiratory Journal 14.2 (1999): 320-327. Web. 27 Oct. 2021.

  14. Similowski, T

    1. Tantucci, C et al "Dynamic hyperinflation and flow limitation during methacholine-induced bronchoconstriction in asthma." European Respiratory Journal 14.2 (1999): 295-301. Web. 27 Oct. 2021.

  15. Simma, B

    1. Burger, R, S Fanconi, and B Simma. "Paralysis of ventilated newborn babies does not influence resistance of the total respiratory system." European Respiratory Journal 14.2 (1999): 357-362. Web. 27 Oct. 2021.

  16. Snoek, WJ

    1. Berge, MV et al "A man with upper respiratory tract infections, general weakness and fever." European Respiratory Journal 14.2 (1999): 469-470. Web. 27 Oct. 2021.

  17. Sosse-Alaoui, H

    1. Labat, C et al "M1/MUC5AC mucin released by human airways in vitro." European Respiratory Journal 14.2 (1999): 390-395. Web. 27 Oct. 2021.

  18. Spengler, CM

    1. Perret, C et al "Noninvasive measurement of respiratory muscle performance after exhaustive endurance exercise." European Respiratory Journal 14.2 (1999): 264-269. Web. 27 Oct. 2021.

  19. Spiliopoulos, A

    1. de Perrot, M et al "Influence of age on operative mortality and long-term survival after lung resection for bronchogenic carcinoma." European Respiratory Journal 14.2 (1999): 419-422. Web. 27 Oct. 2021.

  20. Strandvik, B

    1. Gilljam, M et al "Therapeutic drug monitoring in patients with cystic fibrosis and mycobacterial disease." European Respiratory Journal 14.2 (1999): 347-351. Web. 27 Oct. 2021.

  21. Suga, M

    1. Suga, M et al "Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases." European Respiratory Journal 14.2 (1999): 376-382. Web. 27 Oct. 2021.
    2. Iyonaga, K et al "Elevated bronchoalveolar concentrations of MCP-1 in patients with pulmonary alveolar proteinosis." European Respiratory Journal 14.2 (1999): 383-389. Web. 27 Oct. 2021.

  22. Sugiura, H

    1. Mashito, Y et al "Sensory nerve activation in airway microvascular permeability in guinea-pig late allergic response." European Respiratory Journal 14.2 (1999): 320-327. Web. 27 Oct. 2021.

  23. Szulc, B

    1. Krakowiak, A, B Szulc, and P Gorski. "Allergy to laboratory animals in children of parents occupationally exposed to mice, rats and hamsters." European Respiratory Journal 14.2 (1999): 352-356. Web. 27 Oct. 2021.

T

  1. Tabka, F

    1. Choudat, D et al "Quantification of the dose of inhaled flour: relation with nonspecific bronchial and immunological reactivities." European Respiratory Journal 14.2 (1999): 328-334. Web. 27 Oct. 2021.

  2. Takanashi, S

    1. Takanashi, S et al "Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers." European Respiratory Journal 14.2 (1999): 309-314. Web. 27 Oct. 2021.

  3. Takata, Y

    1. Takata, Y et al "Phospholipase A2 augments contraction and intracellular calcium mobilization through thromboxane A2 in bovine tracheal smooth muscle." European Respiratory Journal 14.2 (1999): 396-404. Web. 27 Oct. 2021.

  4. Tantucci, C

    1. Tantucci, C et al "Dynamic hyperinflation and flow limitation during methacholine-induced bronchoconstriction in asthma." European Respiratory Journal 14.2 (1999): 295-301. Web. 27 Oct. 2021.

  5. Taylor, DR

    1. Hancox, RJ et al "Tolerance to beta-agonists during acute bronchoconstriction." European Respiratory Journal 14.2 (1999): 283-287. Web. 27 Oct. 2021.

  6. Thomas de Montpreville, V

    1. Labat, C et al "M1/MUC5AC mucin released by human airways in vitro." European Respiratory Journal 14.2 (1999): 390-395. Web. 27 Oct. 2021.

  7. Thompson, PJ

    1. Watkins, DN et al "Expression and localization of cyclo-oxygenase isoforms in non-small cell lung cancer." European Respiratory Journal 14.2 (1999): 412-418. Web. 27 Oct. 2021.

  8. Tournier, G

    1. Osika, E et al "Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease." European Respiratory Journal 14.2 (1999): 339-346. Web. 27 Oct. 2021.

  9. Town, GI

    1. Hancox, RJ et al "Tolerance to beta-agonists during acute bronchoconstriction." European Respiratory Journal 14.2 (1999): 283-287. Web. 27 Oct. 2021.

  10. Troosters, T

    1. Troosters, T, R Gosselink, and M Decramer. "Six minute walking distance in healthy elderly subjects." European Respiratory Journal 14.2 (1999): 270-274. Web. 27 Oct. 2021.

V

  1. Vaiman, E

    1. Vaiman, E et al "T-cell chronic lymphocytic leukaemia with pulmonary involvement and relapsing BOOP." European Respiratory Journal 14.2 (1999): 471-474. Web. 27 Oct. 2021.

  2. Villette, C

    1. Choudat, D et al "Quantification of the dose of inhaled flour: relation with nonspecific bronchial and immunological reactivities." European Respiratory Journal 14.2 (1999): 328-334. Web. 27 Oct. 2021.

W

  1. Walls, AF

    1. Roberts, JA et al "The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma." European Respiratory Journal 14.2 (1999): 275-282. Web. 27 Oct. 2021.

  2. Walters, EH

    1. Ward, RJ et al "A critical evaluation of the Mefar dosimeter." European Respiratory Journal 14.2 (1999): 430-434. Web. 27 Oct. 2021.

  3. Ward, RJ

    1. Ward, RJ et al "A critical evaluation of the Mefar dosimeter." European Respiratory Journal 14.2 (1999): 430-434. Web. 27 Oct. 2021.

  4. Watkins, DN

    1. Watkins, DN et al "Expression and localization of cyclo-oxygenase isoforms in non-small cell lung cancer." European Respiratory Journal 14.2 (1999): 412-418. Web. 27 Oct. 2021.

  5. Webb, AK

    1. Haworth, CS et al "Hip fracture and bone histomorphometry in a young adult with cystic fibrosis." European Respiratory Journal 14.2 (1999): 478-479. Web. 27 Oct. 2021.
    2. Hendry, J et al "Cystic fibrosis: inflammatory response to infection with Burkholderia cepacia and Pseudomonas aeruginosa." European Respiratory Journal 14.2 (1999): 435-438. Web. 27 Oct. 2021.

  6. Wey, HM

    1. Perret, C et al "Noninvasive measurement of respiratory muscle performance after exhaustive endurance exercise." European Respiratory Journal 14.2 (1999): 264-269. Web. 27 Oct. 2021.

  7. Wilson, R

    1. Dowling, RB et al "Effect of fluticasone propionate and salmeterol on Pseudomonas aeruginosa infection of the respiratory mucosa in vitro." European Respiratory Journal 14.2 (1999): 363-369. Web. 27 Oct. 2021.

  8. Wilson, S

    1. Roberts, JA et al "The long-acting beta2-agonist salmeterol xinafoate: effects on airway inflammation in asthma." European Respiratory Journal 14.2 (1999): 275-282. Web. 27 Oct. 2021.

  9. Wislez, M

    1. Wislez, M et al "Lymphoma of pulmonary mucosa-associated lymphoid tissue: CT scan findings and pathological correlations." European Respiratory Journal 14.2 (1999): 423-429. Web. 27 Oct. 2021.

  10. Wouters, EF

    1. Coppoolse, R et al "Interval versus continuous training in patients with severe COPD: a randomized clinical trial." European Respiratory Journal 14.2 (1999): 258-263. Web. 27 Oct. 2021.

Y

  1. Yamamoto, K

    1. Takanashi, S et al "Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers." European Respiratory Journal 14.2 (1999): 309-314. Web. 27 Oct. 2021.

  2. Yamamoto, T

    1. Iyonaga, K et al "Elevated bronchoalveolar concentrations of MCP-1 in patients with pulmonary alveolar proteinosis." European Respiratory Journal 14.2 (1999): 383-389. Web. 27 Oct. 2021.

  3. Yamasaki, H

    1. Suga, M et al "Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases." European Respiratory Journal 14.2 (1999): 376-382. Web. 27 Oct. 2021.

  4. Yeadon, M

    1. Labat, C et al "M1/MUC5AC mucin released by human airways in vitro." European Respiratory Journal 14.2 (1999): 390-395. Web. 27 Oct. 2021.

  5. Yokoyama, M

    1. Takata, Y et al "Phospholipase A2 augments contraction and intracellular calcium mobilization through thromboxane A2 in bovine tracheal smooth muscle." European Respiratory Journal 14.2 (1999): 396-404. Web. 27 Oct. 2021.

  6. Yoshihara, S

    1. Linden, A et al "Bronchodilation by pituitary adenylate cyclase-activating peptide and related peptides." European Respiratory Journal 14.2 (1999): 443-451. Web. 27 Oct. 2021.

Z

  1. Zelter, M

    1. Tantucci, C et al "Dynamic hyperinflation and flow limitation during methacholine-induced bronchoconstriction in asthma." European Respiratory Journal 14.2 (1999): 295-301. Web. 27 Oct. 2021.

  2. Zoia, MC

    1. Cerveri, I et al "International variations in asthma treatment compliance: the results of the European Community Respiratory Health Survey (ECRHS)." European Respiratory Journal 14.2 (1999): 288-294. Web. 27 Oct. 2021.
Back to top

Search Within This Issue

Jump to

Manage Table of content Alerts